Literature DB >> 2094186

Computed tomography in neurocysticercosis: a 10-year long evolution analysis of 100 patients with an appraisal of a new classification.

L R Machado1, J P Nobrega, N G Barros, J A Livramento, L A Bacheschi, A Spina-França.   

Abstract

Three hundred and fifty seven computed tomography (CT) from 100 different patients with neurocysticercosis (NC) were studied between 1979 and 1988. All patients were treated with praziquantel (PZQ). A new classification attempting to recognize the CT evolution profile in NC as well as assigning a possible link between CT findings and biological conditions of cysts is evaluated. It was possible to conclude that: intact cysts remain unchanged in consecutive CTs by 11 months and exhibit signs of degeneration in about 18 months after PZQ drug therapy; degenerating cysts can be detected by 10.5 months, disappear in 11 months and become nodular calcifications in about 25 months. Therefore, a time period of at least 36 months can be estimated for the complete evolution profile of cysts in the brain parenchyma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2094186     DOI: 10.1590/s0004-282x1990000400003

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  5 in total

1.  Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis.

Authors:  E C Bueno; A J Vaz; L R Machado; J A Livramento; S L Avila; A W Ferreira
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Specific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples.

Authors:  E C Bueno; A J Vaz; L D Machado; J A Livramento; S R Mielle
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis.

Authors:  A X Pardini; A J Vaz; L Dos Ramos Machado; J A Livramento
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

4.  Use of Taenia crassiceps cysticercus antigen preparations for detection of antibodies in cerebrospinal fluid samples from patients with neurocysticercosis (Taenia solium).

Authors:  Alessandra Xavier Pardini; Regina Helena Peralta; Adelaide José Vaz; Luis dos Ramos Machado; José Mauro Peralta
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 5.  Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.

Authors:  L Monteiro; J Almeida-Pinto; A Stocker; M Sampaio-Silva
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.